Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
professor whose research project is to be primarily registered with the CERMAV laboratory (UPR5301), aiming to develop a project on the design of new glycopolymer biomaterials with controlled architectures
-
the entire value chain – from forest economics, policy, and business administration to biomaterials, wood science, and technology. By integrating social science and technological perspectives, we carry out
-
vigorous research program that applies artificial intelligence, machine Learning and quantum computing to challenges in pharmacology, biomaterials, immuno-inflammatory diseases, and neurosciences. To support
-
21 Feb 2026 Job Information Organisation/Company Delft University of Technology (TU Delft) Research Field Engineering » Biomaterial engineering Engineering » Materials engineering Researcher Profile
-
, Materials Engineering, Biomaterials, and related fields. 2. Financing Source: H2020 – ERC 2019 AdvG GA 883370. 3. Admission Requirements: Doctor Degree in Chemistry, Physics, Physical Engineering, Materials
-
, research strengths include materials for transportation and infrastructure, materials for energy, materials for microelectronics, biomaterials, polymeric materials, and computational and AI materials. In
-
, experimental and computational cell and tissue mechanobiology, biomaterials, computational biomechanics and digital-twin development for next generation medical innovation. The successful candidate shall possess
-
competence (Microfluidics / Nanobiotechnologies) in a pre-industrialization context. Where to apply Website https://emploi.cnrs.fr/Candidat/Offre/UMR7197-SOUBOU-003/Candidater.aspx Requirements Research
-
Holiday Entitlement: 33 days annual leave, plus 9 buildings closed days for all full time staff. Use our total rewards calculator: https://www.hw.ac.uk/about/work/total-rewards-calculator.htm to see the
-
of Pharmacology (Division of Oral Biology and Biomaterials Science, Graduate School of Dentistry, the University of Osaka) is studying on the mechanisms and novel drug therapy of neuropsychiatric disorders and